Identifying risk factors for development of nephrolithiasis in end-stage renal disease patients
Open Access
- 4 July 2019
- journal article
- research article
- Published by Canadian Urological Association Journal in Canadian Urological Association Journal
- Vol. 14 (5) , E185-E190
Abstract
Introduction: We sought to assess the incidence and risk factors for stone development in patients with end-stage renal disease (ESRD) on hemodialysis (HD). Methods: Medical records of patients receiving HD between 2007 and 2017 were retrospectively reviewed. Patients who had been on HD for at least three months and had imaging studies (computed tomography [CT] scans or ultrasound [US]) pre- and post-initiation of HD were included. Exclusion criterion was presence of stones pre-HD. De novo stones were defined as renal stones found on followup imaging. Demographics, laboratory data, comorbidities, and dialysis characteristics were compared between non-stone-formers and stone-formers using propensity score matching. Results: A total of 133 patients met the inclusion criteria. Their median age was 68.5 years, median body mass index 28.7 kg/m2, and median dialysis duration 59.5 months. After HD, 14 (10.5%) patients developed de novo stones and their median dialysis-to-stone duration was 23.5 months. When compared with non-stone-formers, stone-formers had significantly lower incidence of hypertension (48.2% vs. 14.3%; p=0.03), lower serum ionized calcium (1.16 vs. 1.07 mmol/L; p=0.01) and magnesium (0.95 vs. 0.81 mmol/L; p=0.01), and significantly higher serum uric acid (281.5 vs. 319.0 mmol/L; p=0.03). Multivariate analysis demonstrated that lower serum ionized calcium (adjusted odds ratio [OR] 0.00001; 95% confidence interval [CI] 0–0.18) and magnesium (adjusted OR 0.0003; 95% CI 0–0.59) were significantly associated with stone formation. Conclusions: The incidence of de novo nephrolithiasis in ESRD patients on HD was 10.5%. Increased serum uric acid, decreased serum magnesium and ionized calcium, and absence of hypertension were associated with increased stone-formation in ESRD patients on HD.Keywords
This publication has 17 references indexed in Scilit:
- Development of Nephrolithiasis in Asymptomatic Hyperuricemia: A Cohort StudyAmerican Journal of Kidney Diseases, 2017
- Inflammation and frailty in the elderly: A systematic review and meta-analysisAgeing Research Reviews, 2016
- Prevalence of Kidney Stones in the United StatesEuropean Urology, 2012
- Preserving residual renal function in dialysis patients: an update on evidence to assist clinical decision makingClinical Kidney Journal, 2011
- Epidemiology of Stone DiseaseUrologic Clinics of North America, 2007
- Evidence against a contribution of conventional urine risk factors to de novo ESRD renal stonesNephrology Dialysis Transplantation, 2005
- URINARY MATRIX CALCULI: OUR EXPERIENCE AT A SINGLE INSTITUTIONJournal of Urology, 2005
- Association between extracellular volume expansion and urinary calcium excretion in normal humansJournal Of Hypertension, 1993
- Urinary matrix calculi consisting of microfibrillar protein in patients on maintenance hemodialysisKidney International, 1979
- FUNCTIONAL HYPOPARATHYROIDISM AND PARATHYROID HORMONE END‐ORGAN RESISTANCE IN HUMAN MAGNESIUM DEFICIENCYClinical Endocrinology, 1976